Searched for
BIONTECH SHOTS
Pfizer CEO tests positive for COVID for a second timePfizer Chief Executive Officer Albert Bourla , 60, back in August had contacted COVID and had started a course of the company's oral COVID-...- BioNTech, Pfizer to start testing universal vaccine for coronavirusesTheir experimental work on shots that go beyond the current approach include T-cell-enhancing shots, designed to primarily protect against ...
- China's Sinovac COVID-19 booster weaker against Omicron: Hong Kong StudySinovac's CoronaVac and state-owned Sinopharm's BBIBP-CorV vaccine are the two most-used vaccines in China.
- U.S. FDA authorizes Pfizer/BioNTech booster for 16- and 17-year-oldsRegulators from the U.S. Centers for Disease Control and Prevention (CDC) likely need to sign off on the shots before the teenagers can beg...
- U.S. FDA authorizes Pfizer/BioNTech booster for 16- and 17-year-oldsThe CDC has identified fewer than 100 cases of Omicron in the United States, but they are expected to increase in the coming weeks and mont...
- BioNTech starts work on Omicron-specific vaccineOver the weekend, the list of countries that have spotted the new variant in travelers grew. Portugal detected 13 cases linked to the new v...
- UAE approves Pfizer COVID-19 vaccine for ages 5-11The United Arab Emirates has approved for emergency use the Pfizer-BioNtech COVID-19 vaccine for children aged 5-11, the health ministry sa...
- BioNTech says repeats of its COVID-19 vaccine better than devising new one, for nowThe German biotech firm said that offering a third dose of its established two-shot vaccine remained the best response to concerns over wan...
- No need yet to adapt Pfizer vaccine for coronavirus variants, says BioNTech chiefA decision to make a switch should be made only if it is clear that the vaccine failed to work or is only offering sub-par protection again...
- Germany recommends combination of AstraZeneca, mRNA shotsThe committee, known by its German acronym STIKO, didn't detail what studies its conclusion was based on. Germany's disease control center ...
- Taiwan says China blocked deal with BioNTech for COVID-19 shotsTaiwan has millions of vaccine doses on order, from AstraZeneca Plc and Moderna Inc, but has received only slightly more than 700,000 to da...
- Vaccine maker BioNTech says no need to waive patentsUgur Sahin, the chief executive of BioNTech, rejected the U.S.-backed proposal to temporarily lift some intellectual property rights for va...
- BioNTech committed to deliver 1.8 billion doses of COVID-19 vaccine this yearBioNTech's first-quarter total revenues were 2.05 billion euros, up from 27.7 million a year earlier, inflated by the vaccine, and includin...
- Europe will reach herd immunity this summer: BioNTech bossWhile the exact threshold required to reach that critical level of immunization remains a matter of debate, experts say a level above 70% w...
- EU to purchase 100 million more vaccine dosesThe announcement offers a much-needed boost to the EU's sluggish and much-criticised vaccine rollout. Sean Marett, the chief business offic...
- EU throws weight behind Pfizer-BioNTech and new technologyIn a stinging rebuke to pharma giant AstraZeneca, the European Union on Wednesday announced plans to negotiate a massive contract extension...
- Pfizer Covid shot neutralises Brazilian strain in lab studyIn lab experiments, the shot demonstrated “roughly equivalent” levels of neutralising activity against the Brazil and UK strains compared w...
- Vaccine dosing intervals: What countries are doing around the worldThere are differences over the merits of alternative dosing strategies, with some arguing the urgency of the pandemic requires flexibility,...
- BioNTech founders warn of vaccine supply gapsThe delays in rolling out the home-grown vaccine have caused consternation in Germany, where some regions had to halt vaccinations within d...
- Oxford COVID-19 vaccine efficacy would look higher if trial tested for severe virusSpeaking in a briefing, Andrew Pollard, director of the Oxford Vaccine Group, said it is hard to explain the different efficacy rates betwe...
Load More
